4-Fluoroselegiline

4-Fluoroselegiline
Clinical data
Trade names	Fludepryl
Identifiers
	IUPAC name N-[1-(4-fluorophenyl)propan-2-yl]-N-methylprop-2-yn-1-amine;
CAS Number	103596-43-6 ;
PubChem CID	128418;
ChemSpider	113833 ;
CompTox Dashboard (EPA)	DTXSID50874435 ;
Chemical and physical data
Formula	C13H16FN
Molar mass	205.276 g·mol−1
3D model (JSmol)	Interactive image;
Density	1.024 ± 0.06 g/cm3
Boiling point	276.2 ± 25 °C (529.2 ± 45.0 °F)
	SMILES CC(CC1=CC=C(F)C=C1)N(C)CC#C;
	InChI InChI=1S/C13H16FN/c1-4-9-15(3)11(2)10-12-5-7-13(14)8-6-12/h1,5-8,11H,9-10H2,2-3H3; Key:MUDUXRHPVDVWHU-UHFFFAOYSA-N;

4-Fluoroselegiline or p-fluoro-L-deprenyl is a substituted amphetamine designer drug. Much like its parent compount, selegiline, it is a selective and irreversible inhibitor of monoamine oxidase B.^[1]

Pharmacology

Pharmacodynamics

4-Fluoroselegiline has a similar pharmacological profile to its parent compound, selegiline.^[2]

A radiolabelled derivative incorporating ¹⁸F is used to study MAO-B inhibition in both in vivo and in vitro experiments.^[3]

Pharmacokinetics

p-Fluoro-L-deprenyl is metabolized to p-fluoro-L-methamphetamine and p-fluoro-L-amphetamine, both of which are active. The levels of substituted amphetamine metabolites in the brain is three times higher following 4-fluoroselegiline administration compared to an equivalent dose of selegiline.^[2]

References

↑ Erdaö, Franciska; Baranyi, Attila; Takács, József; Arányi, Péter (3 August 2000). "Different neurorescue profiles of selegiline and p-fluoro-selegiline in gerbils". NeuroReport. 11 (11): 2597–3100. doi:10.1097/00001756-200008030-00049. ISSN 0959-4965. PMID 10943729. S2CID 20944931. Retrieved 4 January 2024.
1 2 Yasar, Sevil; Gaal, Jozsef; Justinova, Zuzana; Bergman, Jack (1 October 2005). "Discriminative stimulus and reinforcing effects of p-fluoro-l-deprenyl in monkeys". Psychopharmacology. 182 (1): 95–103. doi:10.1007/s00213-005-0063-y. ISSN 1432-2072. PMID 15990999. S2CID 444126.
↑ Plenevaux, Alain; Fowler, Joanna S.; Dewey, Stephen L.; Wolf, Alfred P.; Guillaume, Marcel (January 1991). "The synthesis of no-c arrier-added DL-4-[18F]fluorodeprenyl via the nucleophilic aromatic substitution reaction". International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes. 42 (2): 121–127. doi:10.1016/0883-2889(91)90060-E. PMID 1648033.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[Erdao_2000-1] Erdaö, Franciska; Baranyi, Attila; Takács, József; Arányi, Péter (3 August 2000). "Different neurorescue profiles of selegiline and p-fluoro-selegiline in gerbils". NeuroReport. 11 (11): 2597–3100. doi:10.1097/00001756-200008030-00049. ISSN 0959-4965. PMID 10943729. S2CID 20944931. Retrieved 4 January 2024.

[Yasar_2005-2] 1 2 Yasar, Sevil; Gaal, Jozsef; Justinova, Zuzana; Bergman, Jack (1 October 2005). "Discriminative stimulus and reinforcing effects of p-fluoro-l-deprenyl in monkeys". Psychopharmacology. 182 (1): 95–103. doi:10.1007/s00213-005-0063-y. ISSN 1432-2072. PMID 15990999. S2CID 444126.

[Plenevaux_1991-3] Plenevaux, Alain; Fowler, Joanna S.; Dewey, Stephen L.; Wolf, Alfred P.; Guillaume, Marcel (January 1991). "The synthesis of no-c arrier-added DL-4-[18F]fluorodeprenyl via the nucleophilic aromatic substitution reaction". International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes. 42 (2): 121–127. doi:10.1016/0883-2889(91)90060-E. PMID 1648033.

[1]

[2]

[3]